Morgenthaler Ventures has worked with outstanding entrepreneurs to build more than 300 companies over 40 years. The Life Science Team has been successful investing in disruptive and novel Medical Device and Biopharmaceutical companies. Helping turn great ideas into great companies is our passion. Here’s our approach.
News
- 04/30/2013 | Fierce Biotech
Biotech upstart joins Big Pharma cast on high-profile ‘breakthrough’ stage - 04/25/2013 | PE Hub
Vapotherm Closes $29 Mln Round - 04/15/2013 | DowJones Venture Wire
Galleon Pharma Seeks $30M Series B - 04/02/2013 | DowJones Venture Wire
Ra Pharma Forms First Corporate Alliance, Strikes $200M Deal With Merck - 02/14/2013 | PR Newswire
Elcelyx Therapeutics Completes $20 Million Series C Financing - 02/11/2013 | DowJones Venture Wire
Holaira Raises $10M for COPD Device - View all